ZA94925B - Silylated acetylcholinesterase inhibitors - Google Patents

Silylated acetylcholinesterase inhibitors

Info

Publication number
ZA94925B
ZA94925B ZA94925A ZA94925A ZA94925B ZA 94925 B ZA94925 B ZA 94925B ZA 94925 A ZA94925 A ZA 94925A ZA 94925 A ZA94925 A ZA 94925A ZA 94925 B ZA94925 B ZA 94925B
Authority
ZA
South Africa
Prior art keywords
silylated
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
ZA94925A
Other languages
English (en)
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA94925B publication Critical patent/ZA94925B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA94925A 1993-02-16 1994-02-10 Silylated acetylcholinesterase inhibitors ZA94925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
ZA94925B true ZA94925B (en) 1994-08-25

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94925A ZA94925B (en) 1993-02-16 1994-02-10 Silylated acetylcholinesterase inhibitors

Country Status (19)

Country Link
EP (2) EP0611769A1 (xx)
JP (1) JP3516955B2 (xx)
KR (1) KR100336547B1 (xx)
CN (1) CN1043575C (xx)
AT (1) ATE152725T1 (xx)
AU (1) AU672885B2 (xx)
CA (1) CA2154870C (xx)
DE (1) DE69403068T2 (xx)
DK (1) DK0684951T3 (xx)
ES (1) ES2104358T3 (xx)
FI (1) FI111461B (xx)
GR (1) GR3024151T3 (xx)
HU (1) HUT72736A (xx)
IL (1) IL108623A0 (xx)
MX (1) MX9401175A (xx)
NO (1) NO305517B1 (xx)
NZ (1) NZ262247A (xx)
WO (1) WO1994019356A1 (xx)
ZA (1) ZA94925B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术(上海)有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
EP2117540A1 (en) 2007-03-01 2009-11-18 Probiodrug AG New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
SG178953A1 (en) 2009-09-11 2012-04-27 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物,其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
IL108623A0 (en) 1994-05-30
DK0684951T3 (da) 1997-05-26
DE69403068D1 (en) 1997-06-12
NO953201L (no) 1995-08-15
ES2104358T3 (es) 1997-10-01
GR3024151T3 (en) 1997-10-31
EP0684951B1 (en) 1997-05-07
WO1994019356A1 (en) 1994-09-01
HUT72736A (en) 1996-05-28
AU6164194A (en) 1994-09-14
CA2154870A1 (en) 1994-09-01
ATE152725T1 (de) 1997-05-15
JP3516955B2 (ja) 2004-04-05
EP0684951A1 (en) 1995-12-06
DE69403068T2 (de) 1997-12-11
JPH08507059A (ja) 1996-07-30
NO305517B1 (no) 1999-06-14
FI111461B (fi) 2003-07-31
KR960701068A (ko) 1996-02-24
EP0611769A1 (en) 1994-08-24
MX9401175A (es) 1994-08-31
FI953851A0 (fi) 1995-08-15
NZ262247A (en) 1996-01-26
CN1043575C (zh) 1999-06-09
CA2154870C (en) 1998-10-27
CN1117733A (zh) 1996-02-28
FI953851A (fi) 1995-08-15
NO953201D0 (no) 1995-08-15
AU672885B2 (en) 1996-10-17
KR100336547B1 (ko) 2002-11-02

Similar Documents

Publication Publication Date Title
IL109863A0 (en) Aromatic acetylcholinesterase inhibitors
IL108623A0 (en) Silylated acetylcholinesterase inhibitors
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
AU2207897A (en) Methods of treating or preventing interstitial cystitis
SG48733A1 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
HU9700598D0 (en) Process for profilacting and treating pancreatitis
EP0630383A4 (en) METHODS OF TREATING DIABETES.
HU9301169D0 (en) Method for improving flame-proofness of plastics by means of addition of guanidine-barbiturates and/or guanidine-thiobarbiturates as burning inhibitors, flame-proof plastics containing said compounds as well as these compounds
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
GB9317943D0 (en) Treatment of laminitis
EP0654996A4 (en) METHOD FOR TREATING PSORIASIS USING SUBSTITUTED AZASPIRANS.
IL95737A0 (en) Fumigant compositions containing carbon disulfide precursors and methods for treating soil using the same
HU9301187D0 (en) Method for treating tumours being dependent of gar-transformylase
EP0608702A3 (de) Verfahren zum Behandeln von Haselnüssen.
EP0932406A4 (en) METHODS OF TREATING OR PREVENTING INTERSTITIAL CYSTITIS
EP0654997A4 (en) COMPOSITIONS OF SUBSTITUTED AZASPIRANS AND METHOD FOR TREATING PSORIASIS THEREFOR.
GB9314466D0 (en) Methods of treating diamonds
GB9326020D0 (en) Novel method of treatment
GB9308853D0 (en) Novel method of treatment